These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21376568)

  • 1. Paediatric intestinal cancer and polyposis due to bi-allelic PMS2 mutations: case series, review and follow-up guidelines.
    Herkert JC; Niessen RC; Olderode-Berends MJ; Veenstra-Knol HE; Vos YJ; van der Klift HM; Scheenstra R; Tops CM; Karrenbeld A; Peters FT; Hofstra RM; Kleibeuker JH; Sijmons RH
    Eur J Cancer; 2011 May; 47(7):965-82. PubMed ID: 21376568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Loss of Function Variants in
    Misceo D; Senaratne LDS; Mero IL; Sundaram AYM; Bjørnstad PM; Szczałuba K; Gasperowicz P; Kamien B; Nedregaard B; Holmgren A; Strømme P; Frengen E
    Genes (Basel); 2023 Oct; 14(11):. PubMed ID: 38002928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rare compound heterozygous mutations in gene
    Ling C; Yang W; Sun H; Ge M; Ji Y; Han S; Zhang D; Zhang X
    Clin Case Rep; 2018 Aug; 6(8):1448-1451. PubMed ID: 30147880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.
    Yurgelun MB; Allen B; Kaldate RR; Bowles KR; Judkins T; Kaushik P; Roa BB; Wenstrup RJ; Hartman AR; Syngal S
    Gastroenterology; 2015 Sep; 149(3):604-13.e20. PubMed ID: 25980754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refining the role of PMS2 in Lynch syndrome: germline mutational analysis improved by comprehensive assessment of variants.
    Borràs E; Pineda M; Cadiñanos J; Del Valle J; Brieger A; Hinrichsen I; Cabanillas R; Navarro M; Brunet J; Sanjuan X; Musulen E; van der Klift H; Lázaro C; Plotz G; Blanco I; Capellá G
    J Med Genet; 2013 Aug; 50(8):552-63. PubMed ID: 23709753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PMS2 monoallelic mutation carriers: the known unknown.
    Goodenberger ML; Thomas BC; Riegert-Johnson D; Boland CR; Plon SE; Clendenning M; Win AK; Senter L; Lipkin SM; Stadler ZK; Macrae FA; Lynch HT; Weitzel JN; de la Chapelle A; Syngal S; Lynch P; Parry S; Jenkins MA; Gallinger S; Holter S; Aronson M; Newcomb PA; Burnett T; Le Marchand L; Pichurin P; Hampel H; Terdiman JP; Lu KH; Thibodeau S; Lindor NM
    Genet Med; 2016 Jan; 18(1):13-9. PubMed ID: 25856668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.
    Bonadona V; Bonaïti B; Olschwang S; Grandjouan S; Huiart L; Longy M; Guimbaud R; Buecher B; Bignon YJ; Caron O; Colas C; Noguès C; Lejeune-Dumoulin S; Olivier-Faivre L; Polycarpe-Osaer F; Nguyen TD; Desseigne F; Saurin JC; Berthet P; Leroux D; Duffour J; Manouvrier S; Frébourg T; Sobol H; Lasset C; Bonaïti-Pellié C;
    JAMA; 2011 Jun; 305(22):2304-10. PubMed ID: 21642682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium 'care for CMMRD' (C4CMMRD).
    Wimmer K; Kratz CP; Vasen HF; Caron O; Colas C; Entz-Werle N; Gerdes AM; Goldberg Y; Ilencikova D; Muleris M; Duval A; Lavoine N; Ruiz-Ponte C; Slavc I; Burkhardt B; Brugieres L;
    J Med Genet; 2014 Jun; 51(6):355-65. PubMed ID: 24737826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline variation in cancer-susceptibility genes in a healthy, ancestrally diverse cohort: implications for individual genome sequencing.
    Bodian DL; McCutcheon JN; Kothiyal P; Huddleston KC; Iyer RK; Vockley JG; Niederhuber JE
    PLoS One; 2014; 9(4):e94554. PubMed ID: 24728327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A homozygous PMS2 founder mutation with an attenuated constitutional mismatch repair deficiency phenotype.
    Li L; Hamel N; Baker K; McGuffin MJ; Couillard M; Gologan A; Marcus VA; Chodirker B; Chudley A; Stefanovici C; Durandy A; Hegele RA; Feng BJ; Goldgar DE; Zhu J; De Rosa M; Gruber SB; Wimmer K; Young B; Chong G; Tischkowitz MD; Foulkes WD
    J Med Genet; 2015 May; 52(5):348-52. PubMed ID: 25691505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avoidance of pseudogene interference in the detection of 3' deletions in PMS2.
    Vaughn CP; Hart KJ; Samowitz WS; Swensen JJ
    Hum Mutat; 2011 Sep; 32(9):1063-71. PubMed ID: 21618646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database.
    Thompson BA; Spurdle AB; Plazzer JP; Greenblatt MS; Akagi K; Al-Mulla F; Bapat B; Bernstein I; Capellá G; den Dunnen JT; du Sart D; Fabre A; Farrell MP; Farrington SM; Frayling IM; Frebourg T; Goldgar DE; Heinen CD; Holinski-Feder E; Kohonen-Corish M; Robinson KL; Leung SY; Martins A; Moller P; Morak M; Nystrom M; Peltomaki P; Pineda M; Qi M; Ramesar R; Rasmussen LJ; Royer-Pokora B; Scott RJ; Sijmons R; Tavtigian SV; Tops CM; Weber T; Wijnen J; Woods MO; Macrae F; Genuardi M
    Nat Genet; 2014 Feb; 46(2):107-115. PubMed ID: 24362816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Mutation Analysis of PMS2 in a Large Cohort of Probands Suspected of Lynch Syndrome or Constitutional Mismatch Repair Deficiency Syndrome.
    van der Klift HM; Mensenkamp AR; Drost M; Bik EC; Vos YJ; Gille HJ; Redeker BE; Tiersma Y; Zonneveld JB; García EG; Letteboer TG; Olderode-Berends MJ; van Hest LP; van Os TA; Verhoef S; Wagner A; van Asperen CJ; Ten Broeke SW; Hes FJ; de Wind N; Nielsen M; Devilee P; Ligtenberg MJ; Wijnen JT; Tops CM
    Hum Mutat; 2016 Nov; 37(11):1162-1179. PubMed ID: 27435373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: report from the constitutional mismatch repair deficiency consortium.
    Bakry D; Aronson M; Durno C; Rimawi H; Farah R; Alharbi QK; Alharbi M; Shamvil A; Ben-Shachar S; Mistry M; Constantini S; Dvir R; Qaddoumi I; Gallinger S; Lerner-Ellis J; Pollett A; Stephens D; Kelies S; Chao E; Malkin D; Bouffet E; Hawkins C; Tabori U
    Eur J Cancer; 2014 Mar; 50(5):987-96. PubMed ID: 24440087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calibration of multiple in silico tools for predicting pathogenicity of mismatch repair gene missense substitutions.
    Thompson BA; Greenblatt MS; Vallee MP; Herkert JC; Tessereau C; Young EL; Adzhubey IA; Li B; Bell R; Feng B; Mooney SD; Radivojac P; Sunyaev SR; Frebourg T; Hofstra RM; Sijmons RH; Boucher K; Thomas A; Goldgar DE; Spurdle AB; Tavtigian SV
    Hum Mutat; 2013 Jan; 34(1):255-65. PubMed ID: 22949387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lynch syndrome caused by germline PMS2 mutations: delineating the cancer risk.
    ten Broeke SW; Brohet RM; Tops CM; van der Klift HM; Velthuizen ME; Bernstein I; Capellá Munar G; Gomez Garcia E; Hoogerbrugge N; Letteboer TG; Menko FH; Lindblom A; Mensenkamp AR; Moller P; van Os TA; Rahner N; Redeker BJ; Sijmons RH; Spruijt L; Suerink M; Vos YJ; Wagner A; Hes FJ; Vasen HF; Nielsen M; Wijnen JT
    J Clin Oncol; 2015 Feb; 33(4):319-25. PubMed ID: 25512458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer.
    Skeldon SC; Semotiuk K; Aronson M; Holter S; Gallinger S; Pollett A; Kuk C; van Rhijn B; Bostrom P; Cohen Z; Fleshner NE; Jewett MA; Hanna S; Shariat SF; Van Der Kwast TH; Evans A; Catto J; Bapat B; Zlotta AR
    Eur Urol; 2013 Feb; 63(2):379-85. PubMed ID: 22883484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing.
    Susswein LR; Marshall ML; Nusbaum R; Vogel Postula KJ; Weissman SM; Yackowski L; Vaccari EM; Bissonnette J; Booker JK; Cremona ML; Gibellini F; Murphy PD; Pineda-Alvarez DE; Pollevick GD; Xu Z; Richard G; Bale S; Klein RT; Hruska KS; Chung WK
    Genet Med; 2016 Aug; 18(8):823-32. PubMed ID: 26681312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
    Richards S; Aziz N; Bale S; Bick D; Das S; Gastier-Foster J; Grody WW; Hegde M; Lyon E; Spector E; Voelkerding K; Rehm HL;
    Genet Med; 2015 May; 17(5):405-24. PubMed ID: 25741868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommendations for interpreting the loss of function PVS1 ACMG/AMP variant criterion.
    Abou Tayoun AN; Pesaran T; DiStefano MT; Oza A; Rehm HL; Biesecker LG; Harrison SM;
    Hum Mutat; 2018 Nov; 39(11):1517-1524. PubMed ID: 30192042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.